nitroxoline
Enable an agent to identify nitroxoline, assess the quality and chemical state of a sample, and determine whether evidence supports its intended handling or use.
Bundle → Layer → Finding → Questions Filled
6 bundles · 11 layers · 17 findings · 27 questions
Nitroxoline identity Establish the exact molecular entity and its relationship to the registered substance.
Substitution pattern
Resolve the quinoline scaffold and positions of the hydroxyl and nitro groups.
Parent structure verification
Require evidence that the assigned molecule is 5-nitroquinolin-8-ol.
- Does the recorded structure place the hydroxyl group at position 8 and the nitro group at position 5? definition
- Which analytical or reference evidence distinguishes this material from positional isomers and nitroso analogues? provenance
Identifier and entity boundaries
Connect substance identifiers while separating the parent from products and derivatives.
Registry identity crosswalk
Reconcile vr.tr.nitroxoline with authoritative identifiers and explicitly scoped related entities.
- Which read sources establish the CAS, PubChem, and any EC identifiers for the same molecular entity? provenance
- Does the record describe nitroxoline itself, a formulation containing it, or a distinct conjugate or isolated complex? boundary
Nitroxoline material quality Determine what a particular lot contains and whether its specification supports the intended use.
Content and impurities
Separate quantitative nitroxoline content from chromatographic purity and other constituents.
Lot composition evidence
Record validated content measurements together with related substances, water, and residual solvents.
- What is the nitroxoline mass fraction, on which reporting basis, and with what analytical uncertainty? measurement
- Which related quinoline impurities, residual solvents, water, or inorganic residues were measured, and at what detection limits? measurement
Grade and release
Tie material acceptance to a named specification and traceable lot evidence.
Intended-use qualification
Assess suitability using the actual lot record and specification rather than the substance name.
- Which certificate, reference standard, and specification establish this lot's claimed grade? provenance
- Do the verified results permit release for the proposed analytical, research, or pharmaceutical use? action
Nitroxoline physical and solution state Describe the conditions under which measured properties apply to the available material.
Solid and thermal state
Characterize the solid without assuming an unverified polymorph, hydrate, or thermal constant.
Solid form and transition evidence
Associate solid-state observations and thermal events with a characterized sample.
- What evidence identifies the sample's crystalline or amorphous state and any solvent or water incorporation? measurement
- Does the reported thermal event represent melting, decomposition, or both, and under which conditions? measurement
Dissolution and speciation
Track dissolved concentration and chemical forms under the actual solvent and medium conditions.
Condition-dependent availability
Distinguish nominal added nitroxoline from dissolved, ionized, or metal-associated material.
- What concentration remains dissolved at the specified solvent composition, pH, temperature, and elapsed time? measurement
- What evidence establishes ionization or metal association under these conditions, and how much unbound nitroxoline remains? measurement
Nitroxoline biological evidence Organize substance-level activity claims with their experimental context and evidential limits.
Antimicrobial assay context
Make organism-specific activity measurements interpretable and comparable.
Activity and exposure record
Attach each antimicrobial result to the tested material, organism, method, and exposure.
- Which organism and strain, inoculum, medium, pH, incubation time, and endpoint define this result? measurement
- Were dissolved exposure, solvent effects, and medium metal content controlled sufficiently to attribute the result to nitroxoline? provenance
Mechanism and translation
Separate measured biological effects, proposed mechanisms, and evidence for practical use.
Claim evidence boundaries
Keep mechanistic hypotheses and investigational uses distinguishable from demonstrated outcomes.
- Which primary experiments support each proposed mechanism, including any contribution from metal binding? provenance
- Does each claim concern a biochemical assay, planktonic growth, biofilm behavior, an animal model, or a human outcome? boundary
Nitroxoline handling and permitted use Connect the material's condition and intended use to substantiated handling and regulatory requirements.
Hazards and preservation
Determine applicable hazards and preservation conditions for the actual form and lot.
Handling and stability basis
Base handling and continued use on dated safety information and relevant stability evidence.
- Which current safety data sheet and underlying evidence establish hazard classifications, exposure controls, and any applicable exposure limits? provenance
- What storage or solution-hold conditions are supported, and what deviations require retesting or rejection? action
Jurisdiction and use status
Resolve legal and quality requirements without confusing substance identity with product authorization.
Applicable use determination
Link proposed activities to dated, jurisdiction-specific records for the appropriate entity.
- Which authoritative records establish requirements for this substance and intended activity in the relevant jurisdiction? provenance
- Does an asserted authorization apply to bulk nitroxoline, a specific finished medicine, or only an investigational use? boundary
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Check these first
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these check these first hold for the sense of nitroxoline this model covers, and on what evidence? provenance
Identifiers and schemes
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these identifiers and schemes hold for the sense of nitroxoline this model covers, and on what evidence? provenance
Real-world use
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these real-world use hold for the sense of nitroxoline this model covers, and on what evidence? provenance
Typical measurements
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these typical measurements hold for the sense of nitroxoline this model covers, and on what evidence? provenance
Failure modes and hazards
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these failure modes and hazards hold for the sense of nitroxoline this model covers, and on what evidence? provenance
Regional variation
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these regional variation hold for the sense of nitroxoline this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of nitroxoline this model covers, and on what evidence? provenance
Classifiers Filled
- Family
- Thing Registry
- Category
- Physical world and living systems
- Entry kind
- thing
- Plane
- PHY
- Domain
- PHY.MAT
What it is Filled
Nitroxoline is 5-nitroquinolin-8-ol, a synthetic nitro-substituted 8-hydroxyquinoline with metal-chelating and antimicrobial activity, used as an antibacterial medicine for urinary tract infections in some countries.
In scope
- Molecular identity and differentiation from related hydroxyquinolines
- Sample composition, purity, grade, and analytical verification
- Solid-state properties, dissolution, ionization, and metal association
- Nitroxoline-specific biological activity and the conditions supporting each claim
- Substance hazard evidence, storage requirements, and jurisdiction-specific identity
Out of scope
- Finished medicinal products, excipients, packaging, and brand identity
- Patient diagnosis, prescribing, dosing, and treatment selection
- Manufacturing processes and production equipment
- Independent models of nitroxoline derivatives, metabolites, and isolated metal complexes
- Organisms, infections, and assay platforms except as linked experimental context
Why it exists Filled
Enable an agent to identify nitroxoline, assess the quality and chemical state of a sample, and determine whether evidence supports its intended handling or use.
Distinguishing features Filled
- The molecular structure must be quinolin-8-ol bearing a nitro group at position 5; a generic hydroxyquinoline label is insufficient. Identity reference: [PubChem Nitroxoline](https://pubchem.ncbi.nlm.nih.gov/compound/Nitroxoline).
- The neutral parent has formula C9H6N2O3 and molar mass 190.16 g/mol, with CAS 4008-48-4 and PubChem CID 19910; matching identifiers should be corroborated by structure. Reference: [PubChem Nitroxoline](https://pubchem.ncbi.nlm.nih.gov/compound/Nitroxoline).
- Structural analysis must distinguish the 5-nitro substituent from a nitroso substituent and confirm that the 8-hydroxyl group is present.
- An identified nitroxoline constituent does not make an entire tablet, mixture, conjugate, or metal complex equivalent to the parent substance.
What robots and AI may and may not do Filled
Must not
- Recommend a dose or course of nitroxoline for a person's infection.
- Present it as authorized in a country where it is not.
- Supply or suggest using expired or unlabelled material as a medicine.
- Release antibacterial material into drains or the environment.
Only with a human decision
- Any decision to use it to treat a person or animal.
- Disposing of quantities of the active substance.
May
- Identify nitroxoline from analytical data and report a sample's grade and storage history.
- Explain its authorized use as a urinary antibacterial where it is approved, citing the source.
Moral aspects Filled
- Misuse of antibacterials drives resistance that harms people beyond the patient.
- Patients may trust online advice over a prescriber who knows their history.
Who is affected
- Patients
- Prescribers and pharmacists
- Laboratory workers
Owners Filled
Steward
The pharmacy, manufacturer or laboratory holding it; the medicines regulator authorizes medicinal use.
Master systems
- National medicines registers
Links to other meta-models Filled
parent
- Q17310777 - registry parent class
What else AI and robots need to interact with it Filled
Identity and identifiers required Filled
- Vercy registry: vr.tr.nitroxoline
- Wikidata: Q304570 (https://www.wikidata.org/wiki/Q304570)
Direct properties required Filled
- Structural identity: Verified connection table and structure identifiers for 5-nitroquinolin-8-ol
- Material form: Neutral parent; ionized species in solution; characterized solid form; mixture containing nitroxoline
- Nitroxoline assay: % w/w with as-is or dry basis; chromatographic area % recorded separately
- Impurity profile: Individual and total impurities in % w/w or mg/kg, with method and detection limits
- Material grade: Reference standard; research reagent; pharmaceutical substance meeting a named specification; unspecified
- Thermal behavior: Melting or decomposition interval in °C with method, atmosphere, and solid form
- Solubility: mg/mL or mol/L with solvent composition, pH, temperature, and equilibration method
- Ionization behavior: pKa values with assigned equilibria, solvent, temperature, and measurement method
- Metal association: Metal species, stoichiometry, free and bound fractions, and supporting evidence
- Antimicrobial activity endpoint: MIC or other named endpoint in mg/L or µmol/L, with organism, strain, medium, and protocol
- Storage condition and stability: Storage history, container, temperature, light and moisture exposure, retest date, and degradation evidence
- Applicable hazard and regulatory record: Dated source, jurisdiction, substance identifier, classification, exposure limit if established, and applicability
Recognition required Filled
- A yellow crystalline powder, which does not settle identity on its own.
- Medicinal products carry a label with the active substance and strength.
- Identity is settled by spectroscopy or chromatography against a reference standard.
Capabilities and actions required Filled
- Match a registry or supplier record to nitroxoline using structural and identifier evidence.
- Assess whether a lot meets a named purity and grade specification for an intended use.
- Calculate nitroxoline quantities from verified assay values and the correct material form.
- Evaluate preparation feasibility using condition-matched solubility, pH, and stability evidence.
- Compare biological activity results while retaining organism, medium, metal content, and endpoint context.
- Select documented handling, storage, and disposal requirements applicable to the actual material.
Hazards and failure modes required Filled
- Inappropriate use contributes to antibacterial resistance.
- Wrong or counterfeit products leave an infection untreated.
- It discolours urine, which can alarm patients who were not told.
Standards and interfaces required Filled
- Globally Harmonized System of Classification and Labelling of Chemicals (GHS), United Nations.
Context of use required Filled
- Nitroxoline is encountered as a pharmaceutical substance and as an antibacterial medicine for urinary tract infections in some countries.
- Laboratory research examines its antimicrobial activity and its ability to bind metal ions.
- Assessing a sample for a specified use requires distinguishing the pure compound from a formulated medicine and checking identity, purity and chemical condition.
Sources Filled
- Wikidata item Q304570: nitroxoline - identity and sense of the item
- Wikipedia: Nitroxoline - general description of the item
Open questions
- Which authoritative EC identifier, hazard classifications, and occupational exposure limits, if any, apply to nitroxoline in the target jurisdictions?
- Which primary measurements establish melting versus decomposition behavior, and is a meaningful boiling-point measurement available before decomposition?
- Which solid forms, pKa values, solubility measurements, and metal-binding equilibria are sufficiently characterized for the intended preparation conditions?
- Which impurity specifications, analytical methods, and stability data support research-grade versus pharmaceutical-grade lot acceptance?
- Which primary studies and current regulatory records establish the boundaries between antimicrobial assay activity, proposed mechanisms, investigational applications, and authorized medicinal use?
Machine files
Provenance
thing registry research (pass 2) · unreviewed
Built from: models/things/publications/thing-q304570/spec.json